As of 2025-11-05, the Relative Valuation of Mirum Pharmaceuticals Inc (MIRM) is (10.75) USD. This relative valuation is based on P/E multiples. With the latest stock price at 70.97 USD, the upside of Mirum Pharmaceuticals Inc based on Relative Valuation is -115.2%.
The range of the Relative Valuation is (8.21) - (14.38) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 4.7x - 12.3x | 8.5x |
| Forward P/E multiples | 7.0x - 12.9x | 10.0x |
| Fair Price | (8.21) - (14.38) | (10.75) |
| Upside | -111.6% - -120.3% | -115.2% |
| Date | P/E |
| 2025-11-03 | -60.78 |
| 2025-10-31 | -62.32 |
| 2025-10-30 | -61.94 |
| 2025-10-29 | -60.45 |
| 2025-10-28 | -60.49 |
| 2025-10-27 | -61.41 |
| 2025-10-24 | -60.07 |
| 2025-10-23 | -59.55 |
| 2025-10-22 | -59.71 |
| 2025-10-21 | -59.18 |
| 2025-10-20 | -62.65 |
| 2025-10-17 | -63.08 |
| 2025-10-16 | -63.84 |
| 2025-10-15 | -65.36 |
| 2025-10-14 | -62.87 |
| 2025-10-13 | -61.91 |
| 2025-10-10 | -62.38 |
| 2025-10-09 | -63.33 |
| 2025-10-08 | -62.50 |
| 2025-10-07 | -63.26 |
| 2025-10-06 | -62.22 |
| 2025-10-03 | -62.58 |
| 2025-10-02 | -61.55 |
| 2025-10-01 | -62.63 |
| 2025-09-30 | -62.89 |
| 2025-09-29 | -62.50 |
| 2025-09-26 | -62.42 |
| 2025-09-25 | -63.11 |
| 2025-09-24 | -63.71 |
| 2025-09-23 | -63.16 |
| 2025-09-22 | -63.42 |
| 2025-09-19 | -63.81 |
| 2025-09-18 | -64.62 |
| 2025-09-17 | -62.75 |
| 2025-09-16 | -63.30 |
| 2025-09-15 | -63.65 |
| 2025-09-12 | -63.75 |
| 2025-09-11 | -65.19 |
| 2025-09-10 | -64.24 |
| 2025-09-09 | -66.65 |
| 2025-09-08 | -66.39 |
| 2025-09-05 | -65.25 |
| 2025-09-04 | -63.64 |
| 2025-09-03 | -64.01 |
| 2025-09-02 | -63.77 |
| 2025-08-29 | -63.37 |
| 2025-08-28 | -64.80 |
| 2025-08-27 | -64.04 |
| 2025-08-26 | -63.65 |
| 2025-08-25 | -61.60 |